137 related articles for article (PubMed ID: 34408946)
1. Treating Low-Grade Myxofibrosarcoma With Stereotactic Body Radiation Therapy Using CyberKnife®.
Mizumatsu S; Ryu H; Nomura K; Yoshikawa S; Inoue N
Cureus; 2021 Jul; 13(7):e16393. PubMed ID: 34408946
[TBL] [Abstract][Full Text] [Related]
2. Effect of CyberKnife stereotactic body radiation therapy for hepatocellular carcinoma on hepatic toxicity.
Liang P; Huang C; Liang SX; Li YF; Huang SX; Lian ZP; Liu JM; Tang Y; Lu HJ
Onco Targets Ther; 2016; 9():7169-7175. PubMed ID: 27920555
[TBL] [Abstract][Full Text] [Related]
3. Urinary Morbidity in Men Treated With Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer Following Transurethral Resection of the Prostate (TURP).
Pepin A; Aghdam N; Shah S; Kataria S; Tsou H; Datta S; Danner M; Ayoob M; Yung T; Lei S; Gurka M; Collins BT; Krishnan P; Suy S; Hankins R; Lynch JH; Collins SP
Front Oncol; 2020; 10():555. PubMed ID: 32432033
[No Abstract] [Full Text] [Related]
4. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated stereotactic radiation therapy for skull base and upper cervical chordoma and chondrosarcoma: preliminary results.
Gwak HS; Yoo HJ; Youn SM; Chang U; Lee DH; Yoo SY; Rhee CH
Stereotact Funct Neurosurg; 2005; 83(5-6):233-43. PubMed ID: 16601376
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionated stereotactic radiation therapy in three to five fractions for vestibular schwannoma.
Morimoto M; Yoshioka Y; Kotsuma T; Adachi K; Shiomi H; Suzuki O; Seo Y; Koizumi M; Kagawa N; Kinoshita M; Hashimoto N; Ogawa K
Jpn J Clin Oncol; 2013 Aug; 43(8):805-12. PubMed ID: 23780990
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer in Men With a High Baseline International Prostate Symptom Score (IPSS ≥ 15).
Aghdam N; Pepin A; Buchberger D; Hirshberg J; Lei S; Ayoob M; Danner M; Yung T; Kumar D; Collins BT; Lynch J; Kataria S; Suy S; Collins SP
Front Oncol; 2020; 10():1060. PubMed ID: 32719744
[No Abstract] [Full Text] [Related]
8. Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: A potential alternative to resection.
Baumann BC; Nagda SN; Kolker JD; Levin WP; Weber KL; Berman AT; Staddon A; Hartner L; Hahn SM; Glatstein E; Simone CB
J Surg Oncol; 2016 Jul; 114(1):65-9. PubMed ID: 27111504
[TBL] [Abstract][Full Text] [Related]
9. Robotic Stereotactic Body Radiation Therapy in Patients With Recurrent or Metastatic Abdominopelvic Tumors: A Single Institute Experience.
Sezen D; Gurkaynak M; Gultekin M; Cengiz M; Yildiz F; Zorlu F; Akyol F; Yazici G; Hurmuz P; Ozyigit G
Technol Cancer Res Treat; 2016 Feb; 15(1):203-11. PubMed ID: 25687510
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
[TBL] [Abstract][Full Text] [Related]
11. Epithelioid variant of myxofibrosarcoma: expanding the clinicomorphologic spectrum of myxofibrosarcoma in a series of 17 cases.
Nascimento AF; Bertoni F; Fletcher CD
Am J Surg Pathol; 2007 Jan; 31(1):99-105. PubMed ID: 17197925
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of using stereotactic body radiation therapy for unresectable soft tissue tumors of the trunk.
Paik EK; Kim MS; Cho CK; Yoo HJ; Jang WI; Seo YS; Jin SH; Jeon DG; Lee DH
Oncotarget; 2018 Jun; 9(45):27851-27857. PubMed ID: 29963242
[TBL] [Abstract][Full Text] [Related]
13. Separation Surgery and Postoperative Intensity-Modulated Radiation Therapy for a High-Grade Myxofibrosarcoma Involving the Spine: A Case Report.
Kanda Y; Yurube T; Kuroda R; Kakutani K
Am J Case Rep; 2023 Mar; 24():e939368. PubMed ID: 36890710
[TBL] [Abstract][Full Text] [Related]
14. Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer.
Temming S; Kocher M; Stoelben E; Hagmeyer L; Chang DH; Frank K; Hekmat K; Wolf J; Baus WW; Semrau R; Baues C; Marnitz S
Strahlenther Onkol; 2018 Feb; 194(2):91-97. PubMed ID: 28812120
[TBL] [Abstract][Full Text] [Related]
15. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
[TBL] [Abstract][Full Text] [Related]
16. Successful Treatment of Facial Merkel Cell Carcinoma Using CyberKnife Radiotherapy Alone: A Case Report.
Mizumatsu S; Fujiyama T
Cureus; 2023 Dec; 15(12):e50699. PubMed ID: 38234949
[TBL] [Abstract][Full Text] [Related]
17. Low toxicity for lung tumors near the mediastinum treated with stereotactic body radiation therapy.
Srivastava R; Asbell SO; Lacouture T; Kramer N; Pahlajani N; Xue J; Ahmad N; Chen Y; Croce R; Grimm J
Pract Radiat Oncol; 2013; 3(2):130-7. PubMed ID: 24674316
[TBL] [Abstract][Full Text] [Related]
18. Postoperative hypofractionated stereotactic brain radiation (HSRT) for resected brain metastases: improved local control with higher BED
Kumar AMS; Miller J; Hoffer SA; Mansur DB; Coffey M; Lo SS; Sloan AE; Machtay M
J Neurooncol; 2018 Sep; 139(2):449-454. PubMed ID: 29749569
[TBL] [Abstract][Full Text] [Related]
19. Curative stereotactic robotic radiotherapy treatment for extracranial, extrapulmonary, extrahepatic, and extraspinal tumors: technique, early results, and toxicity.
Nuyttens JJ; Prevost JB; Van der Voort van Zijp NC; Hoogeman M; Levendag PC
Technol Cancer Res Treat; 2007 Dec; 6(6):605-10. PubMed ID: 17994790
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiotherapy for central lung tumors.
Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
